Arizona Oncology Associates

Summary

Arizona Oncology Associates is a medical facility located in Tucson, Arizona. This center is recognized for care of Lung Cancer, Breast Cancer, Pancreatic Cancer, Cancer, Ovarian Cancer and other specialties. Arizona Oncology Associates is involved with conducting 75 clinical trials across 89 conditions. There are 5 research doctors associated with this hospital, such as Joseph Buscema, MD, Sudhir Manda, Suresh Mukkamala, MD, and Joesph Buscema, MD.

Top PIs

Clinical Trials running at Arizona Oncology Associates

Breast Cancer

Ovarian Cancer

Melanoma

Cancer

Multiple Myeloma

Endometrial Cancer

Cervical Cancer

Kidney Cancer

Stomach Cancer

Squamous Cell Carcinoma

PCS6422 + Capecitabine

for Breast Cancer

This is an adaptive Phase 2, open-label, randomized, multi-center study evaluating up to 2 regimens of PCS6422 with capecitabine (Cap) vs. standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy and safety of PCS6422 + Cap as a treatment option for patients with advanced or metastatic breast cancer who are not eligible for anthracycline- or taxane-containing therapies, or other available therapies, including PD-1 or PARP inhibitors.

Recruiting

1 award

Phase 2

4 criteria

TTX-080 +/− Cetuximab/Pembrolizumab

for Cancer

This trial tests TTX-080, a new drug, alone and with other cancer drugs in patients with hard-to-treat cancers. It works by helping the immune system find and attack cancer cells.

Recruiting

1 award

Phase 1

4 criteria